Use of ipriflavone to reduce the number of cd8+ cells

Details Use of ipriflavone to reduce the number of cd8+ cells Use of ipriflavone to reduce the number of cd8+ cells

A - Human Necessities

61

K

A61K 31/35 (2006.01) A61K 31/352 (2006.01)

Patent

CA 2227421

The present invention relates to pharmaceutical composition suitable to decrease the number of CD8+ cells comprising as active ingredient 7-isopropoxyisoflavone in admixture with suitable inert, solid or liquid carriers and optionally with usual therapeutic additives and auxiliary agents. The pharmaceutical composition according to the invention are prepared by known methods and are suitable for the treatment of human or animal subjects being in a condition where selective suppression of CD8+ lymphocytes is desirable.

La présente invention concerne une composition pharmaceutique appropriée pour diminuer le nombre de cellules CD8+ comprenant comme principe actif de la 7-isopropoxyisoflavone en mélange avec des transporteurs inertes appropriés, solides ou liquides, et, facultativement, des additifs et adjuvants thérapeutiques usuels. La composition pharmaceutique de l'invention est préparée par des méthodes connues et convient pour le traitement des sujets humains ou animaux dont l'état rend souhaitable la suppression sélective des lymphocytes CD8+.

Affiliated with

Also associated with

Rating

Use of ipriflavone to reduce the number of cd8+ cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of ipriflavone to reduce the number of cd8+ cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ipriflavone to reduce the number of cd8+ cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1758809